Safety and Tolerability of Monoclonal Antibody Therapies for Treatment of COVID-19 in Pediatric Patients
Gregory Mak, Aimee M. Dassner, Benjamin M. Hammer, Benjamin R. Hanisch
Abstract
There is a little data regarding safety or efficacy of monoclonal antibody treatment for mild-to-moderate COVID-19 in pediatric patients despite it being frequently used in adults. This retrospective study of 17 patients with mild-to-moderate COVID-19 who received monoclonal antibody therapy found that the treatment was well tolerated, safe, and may be effective in halting progression to severe disease.
Topics & Concepts
MedicineMonoclonal antibodyTolerabilityMonoclonal antibody therapyInternal medicineAntibodyMonoclonalRetrospective cohort studyAntibody therapyOncologyClinical trialImmunologyAdverse effectImmunotherapyImmunopathologyDiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesKawasaki Disease and Coronary Complications